Mark Mossler

Chief Accounting Officer

Equibles does not estimate personal net worth.

Get an email with a short summary when C4 Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get CCCC alerts

About Mark Mossler

Mark Mossler is recorded as Chief Accounting Officer at C4 Therapeutics, Inc. (CCCC) since September 18, 2023. C4 Therapeutics, Inc. reported in an 8-K filed September 5, 2023 that Mark Mossler was appointed Chief Accounting Officer and principal accounting officer, effective September 18, 2023. C4 Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at C4 Therapeutics, Inc. includes Andrew J. Hirsch (CEO), Andrew Phillips (CEO), Ron Cooper (Chairman and Board Member) and 7 others.

“The Company has also appointed Mark Mossler as its Chief Accounting Officer and principal accounting officer, effective as of Monday September 18, 2023.”

C4 Therapeutics, Inc. Form 8-K, filed September 5, 2023 · Read the filing

Affiliation history

C4 Therapeutics, Inc. (CCCC)
Chief Accounting Officer

SEC 8-K

Current
2023-09-18–present

Company network

C4 Therapeutics, Inc.

CCCC

Current role

Biotechnology · Healthcare

Chief Accounting Officer

2023-09-18–present

Leadership on record at C4 Therapeutics, Inc.

Andrew J. Hirsch CEO
Andrew Phillips CEO
Ron Cooper Chairman, Board Member
Kendra R. Adams CFO, Chief Accounting Officer
Lauren White Chief Accounting Officer
William T. McKee Chief Accounting Officer
Adam S. Crystal Board Member
Donna Grogan, M.D. Board Member
Laura Bessen, M.D. Board Member
Owen P. Hughes, Jr. Board Member

Recent activity

Executive change Appointed: Chief Accounting Officer and principal accounting officer C4 Therapeutics, Inc. (CCCC)
2023-09-18